earnings

Showing 15 posts of 19 posts found.

sanofi_hq_reception_close

Earnings drop at Sanofi as it looks for a quick Medivation resolution

July 29, 2016
Medical Communications, Research and Development 2016, Medivation, Q2, Sanofi, earnings

Sanofi has published its earnings results for Q2, which show a fall in sales and profits as their diabetes division …

Germany’s Merck Q1 profits double boosted by Sigma-Aldrich deal

May 19, 2016
Business Services, Sales and Marketing Financial, Merck, Q1, Sigma-Aldrich, deal, earnings, results

Germany’s Merck on Thursday said first-quarter net profit more than doubled helped by the integration of US laboratory equipment maker …

allergan

Allergan to buy back $10 billion of stock, Q1 earnings rise

May 11, 2016
Research and Development, Sales and Marketing Allergan, Buy Back, Financial, Q1, earnings, results, revenue

Botox-maker Allergan (NYSE: AGN) said it plans to buy back as much as $10 billion in stock after completing the …

stocks3

Endo shares plunge almost 40% as company cuts FY outlook

May 9, 2016
Sales and Marketing Endo International, earnings, outlook, revenue

Shares in Endo International (Nasdaq: ENDP) plunged to close down nearly 40% after the company cut its full-year earnings forecast …

merck

Merck & Co Q1 sales hurt by generics, currency impact

May 6, 2016
Medical Communications, Sales and Marketing Financial, Merck & Co, Q1, Revenye, earnings, results, sales

US pharma major Merck & Co (NYSE: MRK) posted a drop in first-quarter sales impacted the launch of generic competition …

Pfizer revenue jumps 20%; ups FY16 outlook

May 4, 2016
Research and Development, Sales and Marketing Pfizer, Q1, earnings, results, revenue, sales

US pharma giant Pfizer (NYSE: PFE) reported a 20% jump in first-quarter revenue boosted by performance of its new cancer …

novo_nordisk_flag

Novo Nordisk Q1 operating profit down 10% in local currencies

April 29, 2016
Medical Communications, Sales and Marketing Financial, Novo Nordisk, Q1, earnings, outlook, results

Denmark’s Novo Nordisk (NYSE: NOV) on Friday posted a 10% drop in first-quarter operating profit and said it maintains its full year …

sanofi_hq__boetie_hall

Sanofi confirm 2016 outlook with Q1 results, EPS rises 5.3%

April 29, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2016, Q1, Sanofi, earnings, outlook, results

Sanofi (EPA: SAN) has confirmed its outlook for 2016 with the publication of their first quarter results, with earnings per …

astrazeneca_sign_sky

AstraZeneca Q1 earnings down 12%; maintains FY view

April 29, 2016
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Q!, earnings, outlook, profits, q, results

UK drugmaker AstraZeneca (LSE: AZN) on Friday reported a 12% drop in first-quarter earnings and said it plans to streamline …

sobi

Sobi profits rise as it rolls out haemophilia drug in Europe

April 28, 2016
Financial, Q1, earnings, results, revenue, sobi

Swedish Orphan Biovitrum (Sobi) (STO: SOBI) nearly doubled its first-quarter profit driven by immediate reimbursements from Germany. The company reported …

gsk-house-location-building

GlaxoSmithKline Q1 earnings up 14% on new product sales

April 27, 2016
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Q1, earnings, results, revenue, sales

GlaxoSmithKline (LSE: GSK) reported a 14% rise in first-quarter earnings driven by demand for new drugs. The UK drug firm …

baxter

Baxter hikes 2016 earnings view driven by strong Q1 results

April 27, 2016
Research and Development, Sales and Marketing Baxalta, FY, Q1, baxter, earnings, outlook, results, revenue

Baxter International (NYSE: BAX) reported better-than-expected first-quarter profits and raised its earnings outlook for 2016. The company now sees earnings …

headquarters_3_web

Eli Lilly Q1 earnings miss estimates, ups FY view; shares drop 2%

April 27, 2016
Research and Development, Sales and Marketing Eli Lilly, FY, Q1, earnings, revenue, sales

Shares in US drugmaker Eli Lilly (NYSE: LLY) dropped to close down over 2% Tuesday after the company posted first-quarter …

biogen_logo

Biogen Q1 profits rise boosted by Tecfidera sales

April 22, 2016
Medical Communications, Sales and Marketing Biogen, Q1, biotech, earnings, results, tecfidera

Shares in Biogen (Nasdaq: BIIB) climbed to close up over 5% Thursday after the company reported 18% rise in first-quarter …

actelion_logo

Actelion ups outlook for 2016, reports Q1 net income up 12%

April 22, 2016
Medical Communications, Sales and Marketing Actelion, Biotechnology, Q1 results, earnings, outlook

Swiss biotech company Actelion (VTX: ATLN) raised its outlook for 2016 and reported a 12% rise in first quarter net …

The Gateway to Local Adoption Series

Latest content